Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Amal Baalash

Amal Baalash

King Fahad Medical City, Saudi Arabia

Title: The relationship between serum levels of igf-1 and components of the metabolic syndrome in Saudi patients

Biography

Biography: Amal Baalash

Abstract

Background: Metabolic syndrome is a clustering of abnormalities including altered glucose tolerance, visceral adiposity, hypertension, and dyslipidemia. Increasing evidence has suggested that IGF-1 may have a role in both glucose homeostasis and cardiovascular disease. Objective: We studied the association between serum IGF-1 concentrations and different components of the metabolic syndrome in Saudi patients. Research Design & Method: A total of 64 Saudi patients with metabolic syndrome (41 females and 23 males) were recruited and anthropometric, blood pressure, IGF-1 levels, and biochemical characteristics were collected. Results: IGF-1 concentrations showed negative correlation with waist circumference in females (r=-0.30206), Triacyleglycerol in both males and females (r=-0.41779 and -0.30436 respectively), and fasting blood sugar in males (r=-0.69667). On the other hand IGF-1 concentrations were positively correlated with HDL cholesterol levels in males (r=0.504247). The results of this study also showed that both systolic and diastolic blood pressure in Saudi females were significantly lower than males. Conclusion: In Saudi patients with metabolic syndrome, low levels of IGF-1 were associated with increased fasting blood sugar, triacylglycerol, and blood pressure, as well as reduced HDL cholesterol. These findings are consistent with an increased cardiovascular risk in such subjects, so more attention should be focused on persons with low IGF-1 levels.